Ticker | Value | Shares | Price | Security | Type | Insider | Title | Return | Flags | Date |
|---|---|---|---|---|---|---|---|---|---|---|
| No transactions found | ||||||||||
Adam J. Townsend currently holds 92,453 shares of Apellis Pharmaceuticals, Inc. (APLS), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Adam J. Townsend has been a net seller of APLS stock. They have purchased $0 and sold $13.0M worth of shares.
Adam J. Townsend's most recent insider trade was on Feb 12, 2024, when they sold 1,148 shares at $67.77 per share.
Adam J. Townsend serves as Executive at Apellis Pharmaceuticals, Inc. (APLS). They have executed 51 insider transactions totaling $13.0M over their tenure at the company.
Adam J. Townsend holds the position of Executive at Apellis Pharmaceuticals, Inc., where they are responsible for executive-level decision-making and strategic oversight. They have been associated with the company for 7 years and currently hold a stake valued at $0.
Adam J. Townsend has shown a selling trading pattern, with $0 in total purchases and $13.0M in total sales across all transactions. Their most recent activity indicates a tendency to reduce their position.
The largest transaction by Adam J. Townsend was on Dec 1, 2023, when they sold $4.1M worth of APLS shares. This transaction involved 67,557 shares at $60.50 per share.
Adam J. Townsend currently owns 92,453 shares of Apellis Pharmaceuticals, Inc. (APLS), with an estimated value of $0. This stake represents their equity holdings accumulated through purchases, awards, and option exercises.
All of Adam J. Townsend's SEC Form 4 insider trading filings are tracked on this page. Each transaction links directly to the official SEC EDGAR filing. Adam J. Townsend has 51 Form 4 filings on record as an insider at Apellis Pharmaceuticals, Inc..
Set alerts for Adam J. Townsend and 40,000+ other insiders.